CEO: Tom Frohlich
Employees: 50
IPO: Apr 29, 2025
Price
$16.02
Change
▲ $1.97
14.02%
Mkt Cap
522.67M
Day Range
$13.93
$16.23
52-Week Range
$6.57
$100.10
Volume
2,228,725
50D / 200D Avg
$14.64
$11.33
Prev Close
$14.05
Quick Summary
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -94.89M
PEG of 0.04 suggests growth is underpriced
Dividend yield of 15.55% — meaningful income
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-62.31%
Below sector avg (3.61%)
ROIC-25.55%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Below sector avg (0.23)
Current Ratio20.33
Interest Coverage0.00
Valuation
P/E Ratio
-4.10
Below sector avg (0.23)
Forward P/EN/A
P/B Ratio1.57
EV/EBITDAN/A
Dividend Yield15.55%
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (638 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.1 | 0.2 |
| P/B | 1.6 | 2.9 |
| ROE % | -62.3 | 3.6 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 9.6 |
| D/E | 0.0 | 0.2 |
Dividend History
Yield
15.55%
Payout Ratio
-0.59%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -127.41M |
| ROE | -62.31% | ROA | -36.43% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -94.89M |
| ROIC | -25.55% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 20.33 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 15.55% | Payout Ratio | -0.59% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4.10 | Forward P/E | N/A |
| P/B Ratio | 1.57 | P/S Ratio | N/A |
| PEG Ratio | 0.04 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -18.15% | ||
| Market Cap | 522.67M | Enterprise Value | 434.95M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -127.41M | -69.63M | -75.52M | -51.51M | -22.96M |
| EPS (Diluted) | -4.06 | -85.26 | -100.38 | -73.67 | -32.96 |
| Gross Profit | -26,000.0 | -282,000.0 | -96,000.0 | -68,000.0 | -15,000.0 |
| Operating Income | -113.54M | -74.60M | -81.41M | -53.24M | -23.02M |
| EBITDA | -113.54M | -69.29M | -75.37M | -51.42M | -22.95M |
| R&D Expenses | 93.12M | 53.19M | 64.22M | 38.62M | 14.99M |
| SG&A Expenses | 20.40M | 21.13M | 17.09M | 14.55M | 8.02M |
| D&A | 26,000.0 | 282,000.0 | 96,000.0 | 68,000.0 | 15,000.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Income Tax | 58,000.0 | 55,000.0 | 56,000.0 | 25,000.0 | 3,000.0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 349.78M | 80.33M | 127.42M | 135.30M | 175.36M |
| Total Liabilities | 17.26M | 3.90M | 17.96M | 8.56M | 2.95M |
| Shareholders' Equity | 332.52M | 76.43M | 109.46M | 126.74M | 172.42M |
| Total Debt | 724,000.0 | 417,000.0 | 675,000.0 | 1.09M | 574,000.0 |
| Cash & Equivalents | 88.44M | 33.75M | 23.49M | 22.40M | 54.20M |
| Current Assets | 336.16M | 80.12M | 124.23M | 131.50M | 174.33M |
| Current Liabilities | 16.54M | 3.83M | 17.64M | 7.78M | 2.55M |